🇺🇸 FDA
Pipeline program

Methylphenidate

NIDA-5-0012-3

Approved small_molecule completed

Quick answer

Methylphenidate for Cocaine-Related Disorders is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 3 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Cocaine-Related Disorders
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials